AmCad BioMed

AmCad BioMed Corporation (安克生醫股份有限公司)

AmCad BioMed Corporation (AmCad) was first founded in 2008. In 2013, AmCad was listed on Taiwan’s Emerging Stock Market and was listed on Taipei on March 24th, 2015. AmCad’s parent companies include Maywufa Company, Ltd (Taiwan Stock Exchange, Code: 1731) and PhytoHealth Corporation (Taiwan Stock Exchange, Code: 4108).

AmCad BioMed Corporation is dedicated to developing innovative Computer-Assisted Detection and Diagnosis (CAD) devices. The company has successfully developed a series of the pioneer, first-in-the world medical devices.

AmCad’s strong pipeline includes AmCAD-UT (FDA, CE Mark and TFDA), AmCAD-UV (CE Mark), AmCAD-US (CE Mark), AmCAD-UO, Am CAD-CA and iSONO accessory. The state of art pipeline aims for early detection of various types of cancers, obstructive sleep apnea and also to help physicians to facilitate current diagnosis procedures.